Article
An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia.
Blood - 25 Jun 2020
Ko Tun Kiat, Javed Asif, Lee Kian Leong, Pathiraja Thushangi N, Liu Xingliang, Malik Simeen, Soh Sheila Xinxuan, Heng Xiu Ting, Takahashi Naoto, Tan Joanna H J, Bhatia Ravi, Khng Alexis J, Chng Wee-Joo, Sia Yee Yen, Fruman David A, Ng King Pan, Chan Zhu En, Xie Kim Jiajing, Hoi Qiangze, Chan Cheryl Xueli, Teo Audrey S M, Velazquez Camacho Oscar, Meah Wee Yang, Khor Chiea Chuen, Ong Chin Thing J, Soon Wei Jia W, Tan Patrick, Ng Pauline C, Chuah Charles, Hillmer Axel M, Ong S Tiong
Abstract excerpt
Targeted therapies against the BCR-ABL1 kinase have revolutionized treatment of chronic phase (CP) chronic myeloid leukemia (CML). In contrast, management of blast crisis (BC) CML remains challenging because BC cells acquire complex molecular alterations that confer stemness features to progenitor populations and resistance to BCR-ABL1 tyrosine kinase inhibitors. Comprehensive models of BC transformation have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
